# ARS Pharmaceuticals, Inc. (SPRY)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SPRY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 86.29M | $ -175.39M | $ -116.83M | $ 96.96M | $ 114.26M |
| 2024 | $ 93.70M | $ 8.41M | $ -97.28M | $ 42.0K | $ 256.80M |
| 2023 | $ 32.4K | $ -58.78M | $ -158.35M | $ 274.0K | $ 230.76M |
| 2022 | $ 1.47M | $ -38.74M | $ -44.99M | $ 481.0K | $ 272.89M |
| 2021 | $ 6.54M | $ -24.06M | $ -158.37M | $ 9.03M | $ -31.27M |
| 2020 | $ 0 | $ -31.63M | $ -16.70M | $ 4.07M | $ 382.88M |
| 2019 | $ 0 | $ -9.00M | N/A | $ 15.62M | $ -5.60M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.85 |
| Liabilities / Eq | 1.87 |
| Current Ratio | 7.28 |

## Other views

- [Metrics](https://sponda.capital/en/SPRY.md)
- [Charts](https://sponda.capital/en/SPRY/charts.md)
- [Compare](https://sponda.capital/en/SPRY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.